APA (7th ed.) Citation

H, Y., Q, H., L, L., D, X., G, Y., Y, W., . . . X, G. (2025). A Novel Liquid Chromatography-Tandem Mass Spectrometry Method for Monitoring Plasma l -Asparaginase Activity in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Pegaspargase Treatment. Therapeutic drug monitoring, 47(6), 755. https://doi.org/10.1097/FTD.0000000000001345

Chicago Style (17th ed.) Citation

H, Yu, et al. "A Novel Liquid Chromatography-Tandem Mass Spectrometry Method for Monitoring Plasma L -Asparaginase Activity in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Pegaspargase Treatment." Therapeutic Drug Monitoring 47, no. 6 (2025): 755. https://doi.org/10.1097/FTD.0000000000001345.

MLA (9th ed.) Citation

H, Yu, et al. "A Novel Liquid Chromatography-Tandem Mass Spectrometry Method for Monitoring Plasma L -Asparaginase Activity in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Pegaspargase Treatment." Therapeutic Drug Monitoring, vol. 47, no. 6, 2025, p. 755, https://doi.org/10.1097/FTD.0000000000001345.